Cargando…

Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.

Detalles Bibliográficos
Autores principales: Millward, M. J., Cantwell, B. M., Dowsett, M., Carmichael, J., Harris, A. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972372/
https://www.ncbi.nlm.nih.gov/pubmed/1903951
_version_ 1782135014343835648
author Millward, M. J.
Cantwell, B. M.
Dowsett, M.
Carmichael, J.
Harris, A. L.
author_facet Millward, M. J.
Cantwell, B. M.
Dowsett, M.
Carmichael, J.
Harris, A. L.
author_sort Millward, M. J.
collection PubMed
description
format Text
id pubmed-1972372
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19723722009-09-10 Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer. Millward, M. J. Cantwell, B. M. Dowsett, M. Carmichael, J. Harris, A. L. Br J Cancer Research Article Nature Publishing Group 1991-05 /pmc/articles/PMC1972372/ /pubmed/1903951 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Millward, M. J.
Cantwell, B. M.
Dowsett, M.
Carmichael, J.
Harris, A. L.
Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
title Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
title_full Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
title_fullStr Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
title_full_unstemmed Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
title_short Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
title_sort phase ii clinical and endocrine study of anandron (ru-23908) in advanced post-menopausal breast cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972372/
https://www.ncbi.nlm.nih.gov/pubmed/1903951
work_keys_str_mv AT millwardmj phaseiiclinicalandendocrinestudyofanandronru23908inadvancedpostmenopausalbreastcancer
AT cantwellbm phaseiiclinicalandendocrinestudyofanandronru23908inadvancedpostmenopausalbreastcancer
AT dowsettm phaseiiclinicalandendocrinestudyofanandronru23908inadvancedpostmenopausalbreastcancer
AT carmichaelj phaseiiclinicalandendocrinestudyofanandronru23908inadvancedpostmenopausalbreastcancer
AT harrisal phaseiiclinicalandendocrinestudyofanandronru23908inadvancedpostmenopausalbreastcancer